Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rakovina Therapeutics Inc (TSE:RKV)
:RKV
Holding TSE:RKV?
Track your performance easily
RKV Stock Chart & Stats
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.21
Previous CloseN/A
VolumeN/A
Average Volume (3M)326.36K
Market Cap
C$17.65M
Enterprise ValueC$9.66M
Total Cash (Recent Filing)$2.81M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.52
Next Earnings
Apr 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding103,817,570
10 Day Avg. Volume242,576
30 Day Avg. Volume326,359
Standard Deviation0.23
R-Squared0.01
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-13.20
P/FCF Ratio0.00
Enterprise Value/Market Cap0.55
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-4.48
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Rakovina Therapeutics Inc News
PremiumCompany Announcements
Rakovina Therapeutics Advances AI-Designed Cancer Drugs to Preclinical Stage
PremiumCompany Announcements
Rakovina Therapeutics to Showcase Cancer Innovations
PremiumCompany Announcements
Rakovina Therapeutics: AI-Driven Success and Financial Growth
PremiumCompany Announcements
Rakovina Therapeutics Debentureholders Opt for Shares
PremiumCompany Announcements
Rakovina Therapeutics Closes $3M Funding Round
PremiumCompany Announcements
Rakovina Therapeutics Showcases Innovation at London Summit
PremiumCompany Announcements
Rakovina Therapeutics Expands Funding for Cancer Research
PremiumCompany Announcements
Rakovina Therapeutics Reports Q3 Results and ProgressOptions Prices
Currently, No data available
---
Ownership Overview
RKV FAQ
What was Rakovina Therapeutics Inc’s price range in the past 12 months?
Rakovina Therapeutics Inc lowest stock price was <C$0.01 and its highest was C$0.20 in the past 12 months.
What is Rakovina Therapeutics Inc’s market cap?
Rakovina Therapeutics Inc’s market cap is C$17.65M.
When is Rakovina Therapeutics Inc’s upcoming earnings report date?
Rakovina Therapeutics Inc’s upcoming earnings report date is Apr 25, 2025 which is in 106 days.
How were Rakovina Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is Rakovina Therapeutics Inc overvalued?
According to Wall Street analysts Rakovina Therapeutics Inc’s price is currently Undervalued.
Does Rakovina Therapeutics Inc pay dividends?
Rakovina Therapeutics Inc does not currently pay dividends.
What is Rakovina Therapeutics Inc’s EPS estimate?
Rakovina Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rakovina Therapeutics Inc have?
Rakovina Therapeutics Inc has 103,817,570 shares outstanding.
What happened to Rakovina Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Rakovina Therapeutics Inc?
Currently, no hedge funds are holding shares in TSE:RKV
---
Company Description
Rakovina Therapeutics Inc
Vincero Capital Corp is a capital pool company. Its principal business is the identification and evaluation of assets or businesses, with a view to completing a qualifying transaction.
---
Technical Analysis
---